Huge News for Broadcom Stock and Nvidia Stock Investors!

The article argues that hyperscalers are increasingly investing in proprietary chip technology, framing this as a repeatable investment signal rather than reporting new operating results. It also highlights Nvidia-related promotional commentary and a 'Total Conviction' signal for a much smaller chipmaker, but provides no concrete earnings, revenue, or guidance figures. Overall, the piece is largely sentiment- and marketing-driven, with limited immediate market impact.

Analysis

The more important signal here is not the promotional framing around one chipmaker, but that hyperscalers are treating custom silicon as a margin-defense tool rather than a pure performance upgrade. That shifts bargaining power away from merchant GPU vendors over a multi-year horizon: every incremental workload moved to in-house ASICs or tightly co-designed chips reduces the addressable share of wallet for third-party accelerators, especially in mature inference workloads where performance per watt matters more than absolute flexibility.

For NVDA, the near-term risk is not an abrupt demand cliff; it is a gradual mix shift. The first-order revenue impact is likely muted for 2-4 quarters because training remains GPU-intensive, but the second-order effect is that hyperscalers increasingly use proprietary chips to cap total capex growth, forcing NVDA into a more contested pricing environment on refresh cycles. AVGO is a structural beneficiary because custom silicon content tends to raise demand for design, interconnect, and networking IP even as it disintermediates generic accelerator exposure.

The contrarian view is that the market may still be underestimating how sticky Nvidia’s ecosystem moat remains. If custom chips proliferate, the bottleneck may move from compute to systems integration, networking, and software compatibility — areas where NVDA can still extract value if it successfully monetizes full-rack deployments. That makes the real question not whether custom silicon grows, but whether NVDA can defend gross margin by becoming the operating layer around the chips rather than just the chip supplier.

Catalyst-wise, watch for capex commentary from large cloud customers over the next 1-2 earnings cycles: any language about “efficiency,” “cost per token,” or “internal optimization” is a leading indicator that proprietary silicon adoption is accelerating. A reversal would require either a step-change in frontier model training needs, or evidence that custom chips are hitting a power, yield, or software limitation that pushes customers back toward merchant GPUs.

Key Decisions for Investors

• Overweight AVGO vs NVDA into the next 1-2 earnings cycles: long AVGO / short NVDA as a relative-value expression of custom-silicon adoption; risk is NVDA re-accelerates on training demand or software monetization.
• If NVDA weakness follows hyperscaler capex commentary, use it to buy 3-6 month call spreads rather than outright stock; the thesis is that displacement is gradual, so downside may be larger than immediate fundamental damage.
• Add a monitoring basket of hyperscaler earnings/guidance as the key catalyst set: look for any capex-to-revenue efficiency rhetoric, which would be the earliest signal to scale the AVGO/NVDA pair.
• For investors already long NVDA, hedge with short-dated upside calls on AVGO or a partial short in an AI infrastructure basket to isolate the custom-chip risk without fully exiting the AI trade.
• Avoid chasing momentum in merchant accelerator names until there is evidence custom silicon has stalled; the risk/reward skews worse over months than days because the market can reprice mix shift before it shows up in reported revenue.